Radioimmunotherapy of colorectal cancer patients with small volume disease:: Results of an ongoing phase-I/II trial.

被引：0
|
作者：
Behr, TM
Liersch, T
Gratz, S
Schmidt, F
Canelo, R
Lorf, T
Post, S
Wörmann, B
Hiddemann, W
Becker, H
Ringe, B
Becker, W
机构：
[1] Univ Gottingen, Dept Nucl Med, D-3400 Gottingen, Germany
[2] Univ Gottingen, Dept Gen Surg, D-3400 Gottingen, Germany
[3] Univ Gottingen, Dept Transplantat Surg, D-3400 Gottingen, Germany
[4] Univ Gottingen, Dept Hematol Oncol, D-3400 Gottingen, Germany
来源：
JOURNAL OF NUCLEAR MEDICINE | 1998年 / 39卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R8 [特种医学]; R445 [影像诊断学];
学科分类号：
1002 ; 100207 ; 1009 ;
摘要：
269
引用
收藏
页码：70P / 70P
页数：1
相关论文
共 50 条
  • [21] NEON ION RADIOTHERAPY - RESULTS OF THE PHASE-I/II CLINICAL-TRIAL
    LINSTADT, DE
    CASTRO, JR
    PHILLIPS, TL
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1991, 20 (04): : 761 - 769
  • [22] TREATMENT OF HEPATIC-METASTATIC COLORECTAL-CANCER WITH A CHEMOTHERAPEUTIC EMULSION - INTERIM RESULTS OF A PHASE-I TRIAL
    RUBIN, JT
    LOTZE, MT
    ROSENFELDER, D
    BRUMFIELD, A
    HOWELLS, R
    SCHWARTZ, R
    SYLVESTRI, S
    SAMMON, J
    BRON, K
    ORENS, P
    ZAJKO, A
    SWANSON, D
    DAY, R
    ANNALS OF SURGICAL ONCOLOGY, 1995, 2 (04) : 351 - 359
  • [23] Effectiveness of Y-90-antitenascin MAbs loco-regional radioimmunotherapy of malignant gliomas:: An ongoing phase II trial.
    Riva, P
    Franceschi, G
    Frattarelli, M
    Riva, N
    Casi, M
    Guiducci, G
    Giuliani, G
    Santimaria, M
    Amato, M
    Mäke, H
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1999, 26 (09): : 969 - 969
  • [24] Interim results of an ongoing phase I trial for the treatment of medullary thyroid cancer (MTC) with radioimmunotherapy (RAIT) combined with doxorubicin-(DOX).
    Hajjar, G
    Sharkey, RM
    Burton, J
    Yeldell, D
    Machado, C
    Mohsen, R
    Rubin, AD
    Goldenberg, DM
    JOURNAL OF NUCLEAR MEDICINE, 2001, 42 (05) : 157P - 158P
  • [25] Irinotecan (CPT-11) in combination with raltitrexed (TX) in patients with previously untreated, advanced colorectal cancer (ACC) patients.: Preliminary results of a phase I/II trial.
    Losa, F
    Manzano, H
    Vicente, P
    Rifa, J
    Ocaña, J
    Balcells, M
    Mediavilla, D
    Heras, L
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 288S - 288S
  • [26] Metronomic capecitabine (cape) and cyclophosphamide (CTX) for refractory metastatic colorectal cancer (mCRC): Results of a phase II trial.
    Marmorino, Federica
    Cremolini, Chiara
    Loupakis, Fotios
    Salvatore, Lisa
    Schirripa, Marta
    Antoniotti, Carlotta
    Di Desidero, Teresa
    Canu, Bastianina
    Orlandi, Paola
    Fioravanti, Anna
    Masi, Gianluca
    Bocci, Guido
    Falcone, Alfredo
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [27] Effect of minocycline on symptom burden and inflammation markers in patients with colorectal cancer: A randomized phase II trial.
    Wang, Xin Shelley
    Shi, Qiuling
    Bhadkamkar, Nishin
    Heijnen, Cobi
    Cleeland, Charles S.
    Eng, Cathy
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [28] Rapamycin has biological activity in a subset of patients with myelodysplastic syndrome - Results of a phase I/II trial.
    Platzbecker, U
    Haase, M
    Herbst, R
    Hanel, A
    Voigtmann, K
    Thiede, C
    Mohr, B
    Schleyer, E
    Leopold, T
    Hanel, M
    Ehninger, G
    Bornhauser, M
    BLOOD, 2004, 104 (11) : 406A - 406A
  • [29] Plitidepsin in patients with advanced colorectal cancer (CRC): Results of an exploratory phase II trial
    Tabernero, Josep M.
    Rivera, Fernando
    Casado, Esther
    Sanchez, Antonio
    Bezares, Susana
    Pico, Cesar
    Paz-Ares, Luis
    ANNALS OF ONCOLOGY, 2006, 17 : 122 - 122
  • [30] Capecitabine in combination with mitomycin C in patients with gastrointestinal cancer: results of an extended multicentre phase-I trial
    R-D Hofheinz
    J T Hartmann
    A Willer
    K Oechsle
    G Hartung
    U Gnad
    S Saussele
    S Kreil
    C Bokemeyer
    R Hehlmann
    A Hochhaus
    British Journal of Cancer, 2004, 91 : 834 - 838
12345